Exenatide, also known as exendin-4, is a 39-amino acid glucagon-like peptide-1 (GLP-1) receptor agonist that acts as an incretin mimetic for the treatment of type II diabetes mellitus [1]. Here, GLP1R is linked to type 2 diabetes mellitus.